<aside> 💡 Founded in 2018 and headquartered in Tokyo, Gellycle Co., Ltd. is a pioneering biotech startup dedicated to the social implementation of "Tetra-Gel" technology developed at the University of Tokyo. This innovative hydrogel platform is characterized by its exceptionally uniform structure, allowing for precise control over physical properties. The technology is primarily targeted at the medical field, including hemostats, anti-adhesion barriers, and regenerative medicine for nerves and tendons. By providing minimally invasive solutions that prioritize patient well-being, Gellycle aims to revolutionize medicine. Their vision extends to environmental and industrial applications, demonstrating a commitment to creating a sustainable and compassionate future through advanced gel engineering. （AS）
</aside>
Gellycle Promotion Video about Tetra hydro gel /ジェリクル株式会社のPV
“Next-Generation” Gel Transforms the Future of Medicine | The Government of Japan - JapanGov -